Drugs / commercially available trivalent influenza vaccine
commercially available trivalent influenza vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02806804 | May → Jun 2016 | — | Beijing Chaoyang District Centre for Disease Control and Prevention | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | commercially available trivalent influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02806804 ↗ |
| Modality | Vaccine | “Biological: one dose commercially available trivalent influenza vaccine” NCT02806804 ↗ |